online glp-1 prescribing often skips clinician interaction, study finds Beware online GLP-1 medication scams

Los agonistas de los receptores GLP-1 y GIP son tratamientos innovadores desarrollados inicialmente para la diabetes, pero que ahora se utilizan para tratar la obesidad

Reddys Laboratories, shared his thoughts: The launch of Colozo marks a significant milestone in our gastrointestinal portfolio in India and builds on our legacy of introducing novel, first-in-class therapies following the successful launch of BixiBat last year

Outcomes included changes in left ventricular ejection fraction (LVEF), end-diastolic volume (LVEDV), end-systolic volume (LVESV), global longitudinal strain (GLS), left ventricular mass, left atrial volume (LAV), and NT-proBNP levels

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Regulate leptin, another fullness hormone, to help you feel full longer

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)